Quantcast
Last updated on April 18, 2014 at 11:15 EDT

Latest Pharmaceutical companies Stories

2012-07-15 22:20:37

LONDON, July 16, 2012 /PRNewswire/ -- With its 15 years conference production and management experience, WTG introduces a leading pharma event: "Early Drug Development Summit" in December 3rd-4th 2012 in Berlin, Germany. The Early Drug Development Summit brings early drug developers together to discuss maximising drug investments, toxicology, safety and biomarkers. We're pleased to announce that Dr.Lucette Doessegger, Global Head of Translational Safety Medicine at...

2012-07-13 06:24:24

PHILADELPHIA, July 13, 2012 /PRNewswire/ -- The law firm of Berger & Montague, P.C. was the first law firm to file a class action against Viropharma Incorporated and Vincent J. Milano in Eastern District of Pennsylvania on May 17, 2012, Docket Number 2:12-CV-02714 on behalf of all investors who purchased shares of Viropharma ("VPHM") between December 14, 2011 and April 9, 2012. The complaint alleges that on December 14, 2011 Viropharma issued a press release announcing the...

2012-07-13 02:22:31

PARSIPPANY, N.J., July 13, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice(TM) ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step®. Watson plans to launch the product immediately. For the twelve months ending May...

2012-07-12 06:24:59

SAN DIEGO, July 12, 2012 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the appointment of Mark F. Morris as Head of Biostatistics effective immediately. In this newly created position, Mr. Morris will oversee the statistical design of the company's human clinical trials. "Mark provides an enormous amount of technical expertise in statistical design and analysis," said Steven J. Mento, Ph.D., President and CEO. "His broad experience in drug development including the hepatology...

2012-07-12 02:28:15

BEDMINSTER, N.J., July 12, 2012 /PRNewswire/ -- This year's 39th Annual Meeting and Exposition of the Controlled Release Society (CRS) will take place in Quebec City, Canada from July 15-18, 2012. Grunenthal's participation in the event will include a booth exhibition as well as hosting an interactive Releasing Technology Workshop. The annual CRS conference offers opportunities to learn about the most recent advancement in drug delivery science, one of which is Grunenthal's tamper resistant...

2012-07-12 02:28:06

PARSIPPANY, N.J., July 12, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Watson's pending acquisition of Actavis Group. The information request was issued under notification requirements of the Hart.Scott Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act"). The effect of...

2012-07-12 02:27:40

SAN DIEGO, July 12, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced it will report second quarter 2012 financial results after the NASDAQ Global Market closes on July 31. The Company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the financial results and highlights for the second quarter as well as provide a corporate update. (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) The conference...

2012-07-12 02:27:33

BRIDGEWATER, N.J., July 12, 2012 /PRNewswire/ -- Sanofi US announced today that its product MACI®( )(matrix-induced autologous chondrocyte implant) met its co-primary endpoint in a two-year, randomized, controlled clinical trial compared to microfracture, a surgical procedure designed to stimulate the growth of new cartilage. MACI uses a patient's own (autologous) cultured cartilage cells (chondrocytes) to repair articular cartilage defects in the knee joint. The results from this pivotal...

2012-07-11 10:23:33

PARSIPPANY, N.J., July 11, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc - Florida has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, the generic equivalent to G.D. Searle's ARTHROTEC®. Watson plans to launch the product in the fourth quarter of 2012. For the twelve months ending...

2012-07-11 06:25:47

TARRYTOWN, N.Y., July 11, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2012 financial and operating results on Wednesday, July 25, 2012, before the U.S. financial markets open. The Company will host a conference call at 8:30 AM EDT that day. Live audio of the conference call will be webcast online simultaneously. A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's...